Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

718
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
718

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Journal for immunotherapy of cancer·2026
Same author

Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome.

Breast cancer research : BCR·2026
Same author

Mid-term outcomes of mechanical thrombectomy for Acute Ischemic stroke in patients with active cancer: a propensity-matched study.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Anti-IgLON5 encephalitis is associated with anti-retinal immunological reactivity without retinal alteration.

Journal of translational autoimmunity·2026
Same author

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.3K

[Autoimmune encephalitis : an update].

Adonis Mattar1, Jérôme Honnorat2, Bastien Joubert3

  • 1Centre français de référence des syndromes neurologiques paranéoplasiques et des encéphalites auto-immunes, Hospices civils de Lyon ; Hôpital neurologique de Bron ; Hôpital neurologique de Lyon, France.

La Revue Du Praticien
|March 8, 2022
PubMed
Summary
This summary is machine-generated.

Autoimmune encephalitis (AE) involves the central nervous system and is linked to anti-neuron antibodies. Treatment focuses on cancer and immune suppression for better patient outcomes.

Keywords:
Autoimmune Diseases

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.9K

Related Experiment Videos

Last Updated: Oct 1, 2025

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.3K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.9K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.9K

Area of Science:

  • Neurology
  • Immunology
  • Neuroscience

Background:

  • Autoimmune encephalitis (AE) are rare central nervous system autoimmune disorders.
  • They are characterized by the presence of anti-neuron antibodies.
  • Clinical presentation varies based on the specific autoantibody involved.

Purpose of the Study:

  • To provide an update on the understanding and management of autoimmune encephalitis.
  • To differentiate between AE subtypes based on antibody targets and prognosis.
  • To highlight diagnostic and therapeutic strategies for AE.

Main Methods:

  • Review of current literature on autoimmune encephalitis.
  • Analysis of clinical presentations associated with different autoantibodies.
  • Discussion of diagnostic approaches, including antibody detection.
  • Overview of management strategies, including immunotherapy and cancer treatment.

Main Results:

  • AE with intracellular antibodies often indicate paraneoplastic syndromes with poor prognosis.
  • AE with cell-surface antibodies are less frequently associated with cancer and generally have better outcomes.
  • Diagnosis is confirmed by detecting specific anti-neuron antibodies.

Conclusions:

  • Autoimmune encephalitis requires accurate diagnosis through antibody detection.
  • Management involves addressing underlying neoplasia and employing immunosuppressive therapies.
  • Distinguishing AE subtypes based on antibody targets is crucial for predicting prognosis and guiding treatment.